These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 12642354)

  • 1. The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis.
    Henry TD; Annex BH; McKendall GR; Azrin MA; Lopez JJ; Giordano FJ; Shah PK; Willerson JT; Benza RL; Berman DS; Gibson CM; Bajamonde A; Rundle AC; Fine J; McCluskey ER;
    Circulation; 2003 Mar; 107(10):1359-65. PubMed ID: 12642354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease.
    Henry TD; Rocha-Singh K; Isner JM; Kereiakes DJ; Giordano FJ; Simons M; Losordo DW; Hendel RC; Bonow RO; Eppler SM; Zioncheck TF; Holmgren EB; McCluskey ER
    Am Heart J; 2001 Nov; 142(5):872-80. PubMed ID: 11685177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of intracoronary recombinant human vascular endothelial growth factor on myocardial perfusion: evidence for a dose-dependent effect.
    Hendel RC; Henry TD; Rocha-Singh K; Isner JM; Kereiakes DJ; Giordano FJ; Simons M; Bonow RO
    Circulation; 2000 Jan; 101(2):118-21. PubMed ID: 10637195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication.
    Rajagopalan S; Mohler ER; Lederman RJ; Mendelsohn FO; Saucedo JF; Goldman CK; Blebea J; Macko J; Kessler PD; Rasmussen HS; Annex BH
    Circulation; 2003 Oct; 108(16):1933-8. PubMed ID: 14504183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A target-mediated model to describe the pharmacokinetics and hemodynamic effects of recombinant human vascular endothelial growth factor in humans.
    Eppler SM; Combs DL; Henry TD; Lopez JJ; Ellis SG; Yi JH; Annex BH; McCluskey ER; Zioncheck TF
    Clin Pharmacol Ther; 2002 Jul; 72(1):20-32. PubMed ID: 12152001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of poly-(D,L-lactide--coglycolide) microsphere formulations containing recombinant human vascular endothelial growth factor to promote local angiogenesis.
    Cleland JL; Duenas ET; Park A; Daugherty A; Kahn J; Kowalski J; Cuthbertson A
    J Control Release; 2001 May; 72(1-3):13-24. PubMed ID: 11389981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: phase II results of the Kuopio Angiogenesis Trial (KAT).
    Hedman M; Hartikainen J; Syvänne M; Stjernvall J; Hedman A; Kivelä A; Vanninen E; Mussalo H; Kauppila E; Simula S; Närvänen O; Rantala A; Peuhkurinen K; Nieminen MS; Laakso M; Ylä-Herttuala S
    Circulation; 2003 Jun; 107(21):2677-83. PubMed ID: 12742981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional Angiogenesis with Vascular Endothelial Growth Factor (VEGF) in peripheral arterial disease: Design of the RAVE trial.
    Rajagopalan S; Mohler E; Lederman RJ; Saucedo J; Mendelsohn FO; Olin J; Blebea J; Goldman C; Trachtenberg JD; Pressler M; Rasmussen H; Annex BH; Hirsch AT;
    Am Heart J; 2003 Jun; 145(6):1114-8. PubMed ID: 12796772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia.
    Losordo DW; Vale PR; Hendel RC; Milliken CE; Fortuin FD; Cummings N; Schatz RA; Asahara T; Isner JM; Kuntz RE
    Circulation; 2002 Apr; 105(17):2012-8. PubMed ID: 11980678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic angiogenesis for ischemic cardiovascular disease.
    Freedman SB; Isner JM
    J Mol Cell Cardiol; 2001 Mar; 33(3):379-93. PubMed ID: 11181008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VEGF therapy in heart disease: for better or for worse?
    Springer ML
    Drug Discov Today; 2002 Feb; 7(4):209-11. PubMed ID: 11839510
    [No Abstract]   [Full Text] [Related]  

  • 12. Vascular growth factors and angiogenesis in cardiac surgery.
    Sellke FW; Ruel M
    Ann Thorac Surg; 2003 Feb; 75(2):S685-90. PubMed ID: 12607713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of intraventricular infusion of vascular endothelial growth factor on cerebral blood flow, edema, and infarct volume.
    Harrigan MR; Ennis SR; Sullivan SE; Keep RF
    Acta Neurochir (Wien); 2003 Jan; 145(1):49-53. PubMed ID: 12545262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic angiogenesis: protein-based therapy for coronary artery disease.
    Khan TA; Sellke FW; Laham RJ
    Expert Opin Pharmacother; 2003 Feb; 4(2):219-26. PubMed ID: 12562312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delivery strategies to achieve therapeutic myocardial angiogenesis.
    Kornowski R; Fuchs S; Leon MB; Epstein SE
    Circulation; 2000 Feb; 101(4):454-8. PubMed ID: 10653839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraventricular infusion of vascular endothelial growth factor promotes cerebral angiogenesis with minimal brain edema.
    Harrigan MR; Ennis SR; Masada T; Keep RF
    Neurosurgery; 2002 Mar; 50(3):589-98. PubMed ID: 11841728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular growth factor and gene therapy to induce new vessels in the ischemic myocardium. Therapeutic angiogenesis.
    Kastrup J; Jørgensen E; Drvota V
    Scand Cardiovasc J; 2001 Oct; 35(5):291-6. PubMed ID: 11771818
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of vascular endothelial growth factor-mediated neointima progression with angiostatin or paclitaxel.
    Celletti FL; Waugh JM; Amabile PG; Kao EY; Boroumand S; Dake MD
    J Vasc Interv Radiol; 2002 Jul; 13(7):703-7. PubMed ID: 12119329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular growth factors for coronary angiogenesis.
    Lee CH; Smits PC
    J Interv Cardiol; 2002 Dec; 15(6):511-8. PubMed ID: 12476656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy with vascular endothelial growth factor reduces angina.
    Merkle CJ; Montgomery DW
    J Cardiovasc Nurs; 2003; 18(1):38-43. PubMed ID: 12537088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.